checkAd

     126  0 Kommentare Ascendis Pharma A/S Announces Full Year 2019 Financial Results and Business Update Conference Call on April 1 - Seite 2

    Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group. March 2020 Ascendis Pharma A/S.

    Investor contact:
    Patti Bank
    Westwicke Partners
    (415) 513-1284
    patti.bank@westwicke.com
    ir@ascendispharma.com
    		                                                       Media contact:
    Ami Knoefler
    Ascendis Pharma
    (650) 739-9952
    ack@ascendispharma.com
         

    Lesen Sie auch

    Seite 2 von 2



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Ascendis Pharma A/S Announces Full Year 2019 Financial Results and Business Update Conference Call on April 1 - Seite 2 COPENHAGEN, Denmark, March 25, 2020 (GLOBE NEWSWIRE) - Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced that the company will hold a …